Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Cross

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Science (New York, N.Y.)|March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
EMI. Animal & Environment|May 19, 2025
Identification and Genomic Characterization of Known and Novel Highly Divergent Sapoviruses in Frugivorous and Insectivorous Bats in NigeriaUwem E George, Lander De Coninck, Oluwadamilola A George, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel Tools for Lassa Virus Surveillance in Peri-domestic RodentsAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
The Lancet. Microbe|April 20, 2026
Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional studyAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Science (New York, N.Y.)|March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
EMI. Animal & Environment|May 19, 2025
Identification and Genomic Characterization of Known and Novel Highly Divergent Sapoviruses in Frugivorous and Insectivorous Bats in NigeriaUwem E George, Lander De Coninck, Oluwadamilola A George, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel Tools for Lassa Virus Surveillance in Peri-domestic RodentsAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
The Lancet. Microbe|April 20, 2026
Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional studyAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
Pageof 13